|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$3,586,438
|
N/A
|
National Institutes of Health
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$18,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$9,000
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$17,798
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$29,931
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$568,908
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of Src kinase in estrogen receptor-positive breast cancer proliferation
|
5F31CA180740-05
|
$37,434
|
$37,434
|
ABDULLAH, CHRISTOPHER
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Postmenopausal women's alcohol study
|
ZIA CP000101-10336
|
$43,293
|
$32,469
|
Abnet, Christian
|
DCEG (NCI)
|
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-03
|
$401,456
|
$401,456
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-09
|
$461,999
|
$461,999
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Li-Fraumeni Syndrome in Brazil
|
ZIA CP010144-10769
|
$12,981
|
$6,490
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
3R01CA171651-05S1
|
$46,696
|
$46,696
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERY
|
5R01CA171651-05
|
$439,171
|
$439,171
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-02
|
$215,047
|
$107,524
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$70,716
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
|
ANALYSIS AND THERAPEUTIC TARGETING OF BREAST CANCER DISSEMINATED TUMOR CELLS
|
5R01CA172623-05
|
$384,803
|
$384,803
|
AFT, REBECCA
|
WASHINGTON UNIVERSITY
|
|
|
High Throughput Mechanical Modulatory Assay for Breast Cancer Drug Testing
|
5R21CA210126-02
|
$207,928
|
$207,928
|
AGAH, MASOUD
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
|
Evaluating mass spectrometry for intraoperative tissue characterization in breast-conserving therapy
|
5R01CA201469-02
|
$406,031
|
$406,031
|
AGAR, NATHALIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$30,988
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$147,440
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
|
5R01CA172119-05
|
$661,913
|
$661,913
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
$156,511
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1.
|
1R43CA217445-01A1
|
$298,729
|
$298,729
|
AKAHATA, WATARU
|
VLP THERAPEUTICS, LLC
|
|
|
Vitamin D Pooling Project
|
ZIA CP010195-10436
|
$28,252
|
$7,063
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$341,964
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
|
Lymphatic and systemic immunity changes in post-radiation lymphedema development
|
5R01CA201487-02
|
$356,147
|
$356,147
|
ALDRICH, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
|
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer
|
5K22CA190653-02
|
$157,743
|
$157,743
|
ALEXANDROVA, EVGUENIA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
5K22CA181550-03
|
$162,000
|
$81,000
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$2,383,555
|
$47,671
|
Alter, Blanche
|
DCEG (NCI)
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$7,125
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$132,279
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
5R01CA208042-02
|
$363,713
|
$363,713
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
3P01CA151135-05S1
|
$300,001
|
$300,001
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$519,415
|
$519,415
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$113,376
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Targeting angiogenesis and vasculogenic mimicry in Triple Negative Breast Cancer
|
1R43CA195882-01A1
|
$300,000
|
$300,000
|
Ammons, William
|
SYNERGYS BIOTHERAPEUTICS, INC.
|
|
|
Role of Splicing Factors in Breast Cancer
|
5R00CA178206-04
|
$249,000
|
$249,000
|
ANCZUKOW-CAMARDA, OLGA
|
JACKSON LABORATORY
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$10,246
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$29,827
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$406,929
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
RIP140 as a mediator of Estrogen Receptor action in tumor associated macrophages
|
1F31CA220978-01
|
$35,245
|
$35,245
|
ANDREANO, KAITLYN
|
DUKE UNIVERSITY
|
|
|
Real-time Cherenkov imaging system for whole-breast radiotherapy verification
|
5F31CA192473-02
|
$44,044
|
$44,044
|
ANDREOZZI, JACQUELINE
|
DARTMOUTH COLLEGE
|
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-04
|
$303,172
|
$303,172
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$206,100
|
$41,220
|
Annunziata, Christina
|
CCR (NCI)
|
|
|
Non-canonical functions of EZH2 in triple-negative breast cancer
|
5F30CA196084-03
|
$34,645
|
$34,645
|
ANWAR, TALHA
|
UNIVERSITY OF MICHIGAN
|
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$95,573
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$436,173
|
$218,086
|
Appella, Ettore
|
CCR (NCI)
|
|
|
The role of the hippocampal-prefrontal network in cancer-related cognitive impairment; a multimodal cross sectional study
|
5F31CA210719-02
|
$38,129
|
$38,129
|
APPLE, ALEXANDRA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
LINE-1 genotoxicity and cytotoxicity and its relevance to cancer
|
1F30CA221175-01
|
$49,044
|
$16,185
|
ARDELJAN, DANIEL
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Cerenkov imaging for in vivo pH determination of the tumor microenvironment
|
5F31CA206453-02
|
$30,962
|
$30,962
|
ARROYO PACHECO, ALEJANDRO
|
UNIVERSITY OF PENNSYLVANIA
|
|
Total relevant funding to Breast for this search: $545,149,951
|
